Safety and effectiveness of retrograde intrarenal surgery versus percutaneous nephrolithotomy in older patients: a systematic review and meta-analysis by the EAU-YAU urolithiasis and EAU endourology sections
BACKGROUND: The comparative efficacy and safety of retrograde intrarenal surgery (RIRS) and percutaneous nephrolithotomy (PCNL) have been extensively evaluated in the general adult population; however, evidence specifically focused on older patients remains limited. Given the underrepresentation of older individuals in comparative studies and the lack of age-specific meta-analytic data, we conducted a systematic review and meta-analysis to evaluate and compare the efficacy and safety of RIRS versus PCNL in the geriatric population. METHODS: A systematic review and meta-analysis were conducted in accordance with PRISMA guidelines. Comparative studies evaluating outcomes of RIRS and PCNL in older patients were identified through comprehensive searches of PubMed/MEDLINE, Embase, Web of Science, and the Cochrane Library up to January 2026. Primary outcomes included overall, minor, and major complications, as well as stone-free rate (SFR). Subgroup analyses were performed according to the age thresholds used to define the geriatric population (≥ 60 and ≥ 65 years). RESULTS: Eight studies including 849 older patients (419 RIRS, 430 PCNL) were analysed. PCNL was associated with a significantly higher final SFR (OR 0.63, 95% CI: 0.43-0.93; p = 0.02). RIRS was associated with lower odds of overall complications (OR 0.54, 95% CI: 0.37-0.80; p = 0.002), minor complications (OR 0.65, 95% CI: 0.43-0.98; p = 0.04), major complications (OR 0.30, 95% CI: 0.12-0.74; p = 0.008), and blood transfusion (OR 0.14, 95% CI: 0.04-0.49; p = 0.002). No significant differences were observed in postoperative fever or sepsis. Operative time did not differ significantly, whereas hospital stay was significantly shorter following RIRS (MD - 2.0 days, 95% CI: -2.6 to - 1.3; p < 0.001). CONCLUSIONS: In older adults, PCNL was associated with higher stone clearance rates, whereas RIRS showed a more favourable safety profile and shorter hospitalisation. Treatment selection should balance efficacy against perioperative morbidity.
Authors
- Matthias Boeykens (ORCID: https://orcid.org/0000-0002-4950-0917)
- Bartosz Małkiewicz (ORCID: https://orcid.org/0000-0002-5933-3753)
- Tomasz Szydełko (ORCID: https://orcid.org/0000-0002-1360-0422)
- Alberto Olivero (ORCID: https://orcid.org/0000-0001-8703-9597)
- Begoña Ballesta Martínez (ORCID: https://orcid.org/0000-0001-8567-0545)
- Agata Góral (ORCID: https://orcid.org/0000-0001-6791-9976)
- Adam Chełmoński
- Jan Łaszkiewicz (ORCID: https://orcid.org/0009-0008-2306-0854)
- Klaudia Żywot
- Wojciech Tomczak
- Thomas Tailly (ORCID: https://orcid.org/0000-0001-5801-5801)
- Theodoros Spinos
- Wojciech Krajewski
- Łukasz Nowak
- Bhaskar Somani
- Amelia Pietropaolo
Institutions
- University of Patras (GR)
- Ghent University Hospital (BE)
- University Hospital Southampton NHS Foundation Trust (GB)
- Wroclaw Medical University (PL)
- Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda (IT)
- Hospital Universitario del Vinalopó (ES)
- AZ Delta (BE)
Publication Details
- Journal
- BMC Geriatrics
- Published
- 2026-06-26
- DOI
- https://doi.org/10.1186/s12877-026-07812-0
- Primary Topic
- Kidney Stones and Urolithiasis Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00